Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Headless Array uses stock pop to raise $52M opportunistically

This article was originally published in Scrip

Executive Summary

In what appears to have been a raid on the public financial markets to take advantage of an elevated stock price, Array BioPharma raised $52 million to advance its multiple research programmes through the sale of 20 million shares at $2.60. Although $2.60 represented a substantial 18.5% discount to its closing stock price of $3.19 on 8 February when the offering was proposed, Array's stock price had bubbled upward nearly 15% at the end of January following well-received second quarter results.


Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts